Olympus Corporation (OCPNF) to Acquire Spiration, a U.S. Pulmonary Device Company, as a Consolidated Subsidiary
6/25/2010 7:17:35 AM
More...
|
Spiration Announces Positive Results of European Study Evaluating Safety and Effectiveness of Bronchial Valve Treatment for Severe Emphysema
5/19/2010 9:41:53 AM
More...
|
Spiration Pulls in $7 Million Debt Financing For Device to Treat Lung Diseases
10/1/2009 8:45:02 AM
More...
|
Centers for Medicare & Medicaid Services Approves New Technology Add-On Payment for Spiration IBV Valve System
8/3/2009 9:19:06 AM
More...
|
Spiration Announces the Participation of Several New Sites in U.S. Pivotal Trial of Minimally Invasive Treatment for Severe Emphysema
7/29/2009 11:59:25 AM
More...
|
Spiration to Present at J.P. Morgan Healthcare Conference
1/8/2009 9:54:08 AM
More...
|
European Respiratory Journal Publishes Results of Computed Tomography Analysis From Pilot Study of Spiration’s Novel Emphysema Treatment
12/4/2008 11:24:09 AM
More...
|
Spiration Receives First FDA Approval for Bronchial Valve
10/27/2008 7:15:16 AM
More...
|
Spiration Signs Agreement with Olympus Medical Systems Corp. for Development and Distribution Rights of Minimally Invasive Pulmonary Device Therapy in Japan
7/24/2008 6:44:44 AM
More...
|
Olympus Medical Systems Corp. and Spiration Sign Agreement to Market and Distribute Minimally Invasive Pulmonary Device in 43 European Countries
5/19/2008 6:32:29 AM
More...
|
|